To investigate the role of ATG9B-4 in promoting malignant features of liver cancer cells through regulating ARNTL–CDK5 axis, the HepG2 cells were transfected with or without ATG9B-4 and si-CDK5. This evidence concerns the gene BMAL1 and liver cancer.